Document center

Study Qualitative evaluation of completed projects funded by the ERC 2019

Published on | 4 years ago

Programmes ERC
ERC monitors the impact of the research funded by organising a qualitative evaluation of the research outcome of finalised projects annually. This study evaluated a total of 225 ERC projects, funded under the European Union’s 7th Framework Programme (FP7), in 25 independent peer-review panels. The study found that 18% of projects analysed had resulted in a scientific breakthrough and 61.9% had made major scientific advances. 17.6% of projects had made an incremental scientific contribution, whilst 2.5% of the assessed projects provided no appreciable scientific contribution. Half of the projects already had an impact on the economy, society and policy-making, and around two thirds are expected to have such impact in the medium to long term.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.